TENS for Pain and Sleep After Hernia Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNigde Omer Halisdemir University

About this trial

This study evaluates whether Transcutaneous Electrical Nerve Stimulation (TENS) improves postoperative pain and sleep quality in adults undergoing inguinal hernia surgery. After surgery, participants will receive physician-supervised TENS or usual care. Pain intensity and sleep quality will be measured and compared between groups to assess the effectiveness and safety of TENS as a supportive recovery method.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (≥18 years) undergoing elective inguinal hernia surgery

Disqualifiers

History of epilepsy, cardiac pacemaker, or other contraindications to TENS

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous Electrical Nerve Stimulation (TENS)

    Device

    Physician-supervised application of TENS to the inguinal region after hernia surgery, following a standardized protocol.

  • Standard Postoperative Care

    Other intervention

    Participants in this arm will receive routine postoperative care following inguinal hernia surgery, without TENS application.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Arm 1 (Experimental): TENS GroupExperimental treatment 1 intervention
Group B: Arm 2: Standard Care GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative Pain Intensity

Pain intensity will be measured using the Visual Analog Scale (VAS) at 6, 12, and 24 hours postoperatively.

Time frame
First 24 hours after surgery
2

Change in Pain Intensity (VAS)

Pain intensity will be measured using the Visual Analog Scale (VAS) at 6, 12, and 24 hours postoperatively.

Time frame
First 24 hours after surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: